SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008058
Filing Date
2024-05-14
Accepted
2024-05-14 07:15:50
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20240331x10q.htm   iXBRL 10-Q 1645194
2 EX-10.1 pasg-20240331xex10d1.htm EX-10.1 38723
3 EX-31.1 pasg-20240331xex31d1.htm EX-31.1 16647
4 EX-31.2 pasg-20240331xex31d2.htm EX-31.2 15980
5 EX-32.1 pasg-20240331xex32d1.htm EX-32.1 6365
6 EX-32.2 pasg-20240331xex32d2.htm EX-32.2 6229
7 GRAPHIC pasg-20240331x10q001.jpg GRAPHIC 74137
  Complete submission text file 0001558370-24-008058.txt   6836192

Data Files

Seq Description Document Type Size
8 EX-101.SCH pasg-20240331.xsd EX-101.SCH 42580
9 EX-101.CAL pasg-20240331_cal.xml EX-101.CAL 41946
10 EX-101.DEF pasg-20240331_def.xml EX-101.DEF 143279
11 EX-101.LAB pasg-20240331_lab.xml EX-101.LAB 396299
12 EX-101.PRE pasg-20240331_pre.xml EX-101.PRE 279944
67 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20240331x10q_htm.xml XML 1150331
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 24941442
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)